244 related articles for article (PubMed ID: 25243327)
1. A survey of prescriber perceptions about the prevention of stress-related mucosal bleeding in the intensive care unit.
Preslaski CR; Mueller SW; Kiser TH; Fish DN; MacLaren R
J Clin Pharm Ther; 2014 Dec; 39(6):658-62. PubMed ID: 25243327
[TBL] [Abstract][Full Text] [Related]
2. Why do physicians prescribe stress ulcer prophylaxis to general medicine patients?
Hussain S; Stefan M; Visintainer P; Rothberg M
South Med J; 2010 Nov; 103(11):1103-10. PubMed ID: 21042168
[TBL] [Abstract][Full Text] [Related]
3. Stress-related mucosal bleeding in critically ill oncology patients.
Bruno JJ; Canada TW; Wakefield CD; Nates JL
J Oncol Pharm Pract; 2009 Mar; 15(1):9-16. PubMed ID: 18753185
[TBL] [Abstract][Full Text] [Related]
4. An interprofessional approach to reducing the overutilization of stress ulcer prophylaxis in adult medical and surgical intensive care units.
Tasaka CL; Burg C; VanOsdol SJ; Bekeart L; Anglemyer A; Tsourounis C; Rennke S
Ann Pharmacother; 2014 Apr; 48(4):462-9. PubMed ID: 24473490
[TBL] [Abstract][Full Text] [Related]
5. Stress ulcer prophylaxis with a proton pump inhibitor versus placebo in critically ill patients (SUP-ICU trial): study protocol for a randomised controlled trial.
Krag M; Perner A; Wetterslev J; Wise MP; Borthwick M; Bendel S; Pelosi P; Keus F; Guttormsen AB; Schefold JC; Møller MH;
Trials; 2016 Apr; 17(1):205. PubMed ID: 27093939
[TBL] [Abstract][Full Text] [Related]
6. Prevention of stress ulceration: current trends in critical care.
Daley RJ; Rebuck JA; Welage LS; Rogers FB
Crit Care Med; 2004 Oct; 32(10):2008-13. PubMed ID: 15483408
[TBL] [Abstract][Full Text] [Related]
7. National survey of stress ulcer prophylaxis.
Lam NP; Lê PD; Crawford SY; Patel S
Crit Care Med; 1999 Jan; 27(1):98-103. PubMed ID: 9934901
[TBL] [Abstract][Full Text] [Related]
8. Stress ulcer prophylaxis in critically ill patients: a randomized controlled trial.
Kantorova I; Svoboda P; Scheer P; Doubek J; Rehorkova D; Bosakova H; Ochmann J
Hepatogastroenterology; 2004; 51(57):757-61. PubMed ID: 15143910
[TBL] [Abstract][Full Text] [Related]
9. Opinions and practice of stress ulcer prophylaxis in Australian and New Zealand intensive care units.
Eastwood GM; Litton E; Bellomo R; Bailey MJ; Festa M; Beasley RW; Young PJ
Crit Care Resusc; 2014 Sep; 16(3):170-4. PubMed ID: 25161018
[TBL] [Abstract][Full Text] [Related]
10. Cost-effectiveness of histamine receptor-2 antagonist versus proton pump inhibitor for stress ulcer prophylaxis in critically ill patients*.
MacLaren R; Campbell J
Crit Care Med; 2014 Apr; 42(4):809-15. PubMed ID: 24365863
[TBL] [Abstract][Full Text] [Related]
11. [Prophylaxis for stress ulcer bleeding in the intensive care unit].
Avendaño-Reyes JM; Jaramillo-Ramírez H
Rev Gastroenterol Mex; 2014; 79(1):50-5. PubMed ID: 24629722
[TBL] [Abstract][Full Text] [Related]
12. Pharmacoepidemiology of stress ulcer prophylaxis in the United States and Canada.
Barletta JF; Kanji S; MacLaren R; Lat I; Erstad BL;
J Crit Care; 2014 Dec; 29(6):955-60. PubMed ID: 25081626
[TBL] [Abstract][Full Text] [Related]
13. Stress ulcer prophylaxis in the intensive care unit: an international survey of 97 units in 11 countries.
Krag M; Perner A; Wetterslev J; Wise MP; Borthwick M; Bendel S; McArthur C; Cook D; Nielsen N; Pelosi P; Keus F; Guttormsen AB; Moller AD; Møller MH;
Acta Anaesthesiol Scand; 2015 May; 59(5):576-85. PubMed ID: 25880349
[TBL] [Abstract][Full Text] [Related]
14. Frequency of inappropriate continuation of acid suppressive therapy after discharge in patients who began therapy in the surgical intensive care unit.
Murphy CE; Stevens AM; Ferrentino N; Crookes BA; Hebert JC; Freiburg CB; Rebuck JA
Pharmacotherapy; 2008 Aug; 28(8):968-76. PubMed ID: 18657013
[TBL] [Abstract][Full Text] [Related]
15. Re-evaluating the Utility of Stress Ulcer Prophylaxis in the Critically Ill Patient: A Clinical Scenario-Based Meta-Analysis.
Reynolds PM; MacLaren R
Pharmacotherapy; 2019 Mar; 39(3):408-420. PubMed ID: 30101529
[TBL] [Abstract][Full Text] [Related]
16. [Bleeding and pneumonia in intensive care unit patients given proton pump inhibitor or histamine-2 receptor antagonist for prevention of stress ulcer: a Meta analysis].
Zhou JF; Wan XY; Huang W; Han LL
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2010 Apr; 22(4):221-5. PubMed ID: 20398466
[TBL] [Abstract][Full Text] [Related]
17. When should stress ulcer prophylaxis be used in the ICU?
Quenot JP; Thiery N; Barbar S
Curr Opin Crit Care; 2009 Apr; 15(2):139-43. PubMed ID: 19578324
[TBL] [Abstract][Full Text] [Related]
18. Stress ulcer prophylaxis in critical illness: a Canadian survey.
Shears M; Alhazzani W; Marshall JC; Muscedere J; Hall R; English SW; Dodek PM; Lauzier F; Kanji S; Duffett M; Barletta J; Alshahrani M; Arabi Y; Deane A; Cook DJ
Can J Anaesth; 2016 Jun; 63(6):718-24. PubMed ID: 26911559
[TBL] [Abstract][Full Text] [Related]
19. Stress ulcer prophylaxis in the intensive care unit: is it indicated? A topical systematic review.
Krag M; Perner A; Wetterslev J; Møller MH
Acta Anaesthesiol Scand; 2013 Aug; 57(7):835-47. PubMed ID: 23495933
[TBL] [Abstract][Full Text] [Related]
20. Patterns of use of prophylaxis for stress-related mucosal disease in patients admitted to the intensive care unit.
Frandah W; Colmer-Hamood J; Nugent K; Raj R
J Intensive Care Med; 2014; 29(2):96-103. PubMed ID: 22786980
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]